Allogenic stem cell transplantation – Diagnostics

Go back

Allogeneic stem cell transplantation is a complex procedure that requires careful evaluation before, during, and after treatment. Understanding the diagnostic process helps patients prepare for what lies ahead, from initial health assessments to monitoring recovery and detecting potential complications. These tests ensure that patients are suitable candidates for transplant and help medical teams track progress throughout the journey.

Introduction: Who Should Undergo Diagnostics

Diagnostics for allogeneic stem cell transplantation serve several important purposes throughout your treatment journey. If your doctor has recommended this procedure, you’ll need a series of tests to determine whether you’re healthy enough to undergo the transplant and to establish a baseline understanding of your condition[3].

People who may benefit from allogeneic stem cell transplantation include those with certain blood cancers, blood disorders, and immune system disorders. Specifically, this treatment is considered for conditions such as acute lymphoblastic leukemia (a fast-growing cancer of white blood cells), acute myeloid leukemia (another type of blood cancer), aplastic anemia (when your bone marrow stops making enough blood cells), lymphoma, myelodysplastic syndrome (a group of disorders where blood cells don’t develop properly), myeloproliferative neoplasms (conditions where bone marrow makes too many blood cells), and sickle cell disease[3].

You should seek diagnostic evaluation when your primary treatments aren’t working effectively or when your condition has returned after initial treatment. Healthcare providers typically recommend stem cell transplants as a second-line option, meaning they try other approaches first. About 40% of people who need a stem cell transplant receive donated stem cells from another person[3].

The timing of diagnostics is crucial. Initial testing happens when your doctor first considers whether transplant is the right option for you. Additional testing occurs before the actual transplant procedure to ensure you’re ready. After transplant, ongoing diagnostic monitoring continues for months or even years to check how well your body is accepting the new cells and to watch for complications.

⚠️ Important
Not everyone is a suitable candidate for allogeneic stem cell transplantation. Your medical team needs to confirm that you’re strong enough to handle the intensive conditioning treatment that comes before the transplant. This is why comprehensive diagnostic testing is so important—it helps protect your safety throughout the process.

Diagnostic Methods

Blood Tests and Complete Blood Count

Before you can undergo an allogeneic stem cell transplant, your transplant team will perform a complete blood count, often shortened to CBC. This fundamental test measures three main types of cells in your blood: red blood cells (which carry oxygen throughout your body), white blood cells (which fight infection), and platelets (tiny cells that help your blood clot when you’re injured)[3].

The complete blood count gives your medical team vital information about your current health status. If your blood cell counts are dangerously low or abnormal, this might affect the timing of your transplant or require additional treatment first. The test involves a simple blood draw from your arm, and results typically come back within a day or two.

Heart Function Tests

Your heart needs to be strong enough to withstand the stress of transplant and the intensive treatments that come with it. That’s why your transplant team will check how well your heart is working using two different tests[3].

An echocardiogram uses sound waves to create moving pictures of your heart. This test shows how well your heart chambers are pumping blood and whether your heart valves are working properly. During the test, a technician places a wand-like device on your chest that sends out sound waves. These waves bounce off your heart structures and create images on a screen. The test is painless and usually takes about 30 to 60 minutes.

An electrocardiogram, shortened to EKG or ECG, records the electrical activity of your heart. Small sticky patches called electrodes are placed on your chest, arms, and legs. These electrodes detect the electrical signals that make your heart beat. The test helps identify irregular heart rhythms or other problems that might complicate your transplant. An EKG takes only a few minutes and causes no discomfort[3].

Liver and Kidney Function Tests

Your liver and kidneys play critical roles in processing the powerful medications you’ll receive during and after transplant. Your medical team needs to know these organs are functioning well enough to handle the workload[3].

Liver function tests measure certain proteins and enzymes in your blood. When your liver is damaged or not working properly, it releases these substances into your bloodstream in abnormal amounts. The tests help doctors understand whether your liver can safely process chemotherapy drugs and other medications.

Similarly, kidney function tests measure waste products in your blood that healthy kidneys normally filter out. If these waste products are building up, it suggests your kidneys might struggle with the additional burden of transplant medications. Both liver and kidney tests require only a blood sample.

Bone Marrow Biopsy

If you have cancer, your transplant team will likely perform a bone marrow biopsy to examine your bone marrow cells more closely. Your bone marrow is the soft, spongy tissue inside certain bones where blood cells are made[3].

During this procedure, a doctor inserts a special needle through your skin and into a bone, usually in your hip. They remove a small sample of bone marrow for examination under a microscope. A medical pathologist (a doctor who specializes in analyzing tissue samples) looks at the cells to check for signs of disease and to understand how active your condition is.

If you’ve already had a bone marrow biopsy to diagnose your blood cancer or blood disorder, your team might do another one before transplant. This repeat biopsy helps them see if your disease has changed and helps predict the risk that your condition might come back after transplant. While the procedure can be uncomfortable, your doctor will use local anesthesia to numb the area, and you may also receive medication to help you relax.

Tissue Typing and HLA Matching

One of the most critical diagnostic tests for allogeneic stem cell transplantation involves finding the right donor. Not just anyone can donate stem cells to you—the donor needs to have a tissue type that closely matches yours[11].

Tissue typing is based on human leukocyte antigens, usually called HLA. These are proteins found on the surface of your white blood cells. HLA proteins are important for your body’s immune system because they help your body recognize which cells belong to you and which are foreign. When foreign cells enter your body, your white blood cells detect them as invaders and attack them.

Finding a close HLA match reduces the risk that your body will reject the donated stem cells or that the donated cells will attack your body (a serious complication called graft versus host disease)[3]. Your siblings have the highest chance of being a match because you inherit HLA types from your parents. Family members will have a blood test to determine their tissue type.

If no family member is a close match, your doctor will help you search for an unrelated donor through donor registries. The National Marrow Donor Program has millions of registered volunteers who have had their blood typed. However, finding an unrelated donor can take weeks or even months. Some patients use stem cells from donated umbilical cord blood, which doesn’t require as close a match[11].

Imaging Studies

Your medical team may order various imaging tests to check for signs of disease in different parts of your body and to assess your overall health. These might include chest X-rays to examine your lungs, CT scans (computed tomography scans that create detailed cross-sectional images), or other specialized imaging depending on your specific condition.

These images help doctors see if your disease has spread to other areas and whether there are any existing health problems that might affect your transplant. For example, if you have an active infection in your lungs, your transplant might need to be delayed until the infection is treated.

Diagnostics for Clinical Trial Qualification

If you’re considering participating in a clinical trial involving allogeneic stem cell transplantation, you’ll need to meet specific criteria that the trial researchers have established. These criteria exist to ensure patient safety and to make sure the study results are reliable and meaningful.

Clinical trials typically require many of the same diagnostic tests described above, but they may have stricter requirements for what the results need to show. For example, a trial might only accept patients whose blood cell counts fall within a certain range, or whose heart function meets specific benchmarks.

Many clinical trials will require a recent bone marrow biopsy to confirm your diagnosis and disease status. The biopsy results must show that your condition matches what the trial is designed to study. If you have cancer, trials often specify whether they’re looking for patients whose disease is in remission, actively progressing, or at a particular stage[3].

Some trials may require additional specialized tests beyond the standard transplant workup. These might include genetic testing to look for specific mutations in your disease cells, or tests to measure certain proteins or markers in your blood. The trial team will explain exactly what tests you need and why they’re important for the study.

Timing matters in clinical trial qualification. Test results usually need to be recent—often within 30 days of starting the trial—to give an accurate picture of your current health. If your tests are older than the trial allows, you’ll need to repeat them.

⚠️ Important
Clinical trials have strict eligibility requirements for good reasons. These requirements help protect your safety and ensure the study can answer important scientific questions. Don’t be discouraged if you don’t qualify for a particular trial—your transplant team can help you find other trials or standard treatment options that are right for you.

Clinical trials may also have exclusion criteria—conditions or characteristics that would prevent you from participating. Common exclusions include having certain other medical conditions, being pregnant, or having received specific treatments in the past. The diagnostic workup helps determine whether any exclusion criteria apply to you.

Your performance status is another important qualification factor for many trials. This is a measure of how well you can carry out daily activities. Your doctor will assess whether you can care for yourself, how much of the day you’re able to be up and active, and whether you need help with basic tasks. Trials often require patients to have a certain level of independence and activity because transplant is very demanding physically.

Throughout the qualification process, the clinical trial team will carefully review all your diagnostic results. If you meet all the criteria, they’ll discuss the trial details with you, including potential risks and benefits. You’ll have time to ask questions and decide whether you want to participate. Remember that joining a clinical trial is always voluntary—you can choose standard treatment instead, or you can leave a trial at any time if you change your mind.

Ongoing Clinical Trials on Allogenic stem cell transplantation

  • Testing Stem Cell Transplant Methods and Medications Including Ruxolitinib and Blinatumomab for Children and Young Adults with Acute Lymphoblastic Leukemia

    Recruiting

    4 1 1 1
    Investigated diseases:
    Austria Czechia Denmark Finland France Germany +3
  • Study on RSV Vaccination with Abrysvo and Arexvy for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

    Recruiting

    4 1 1 1
    Investigated diseases:
    Belgium
  • Study on Fecal Microbiota Transplantation to Prevent Complications in Patients After Stem Cell Transplant for Blood Cancer

    Recruiting

    2 1 1
    Investigated drugs:
    France
  • Study on Ivosidenib for Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome with IDH1 Mutation After Stem Cell Transplant

    Recruiting

    2 1 1 1
    Investigated drugs:
    Germany
  • Study of iG-Tregs for Preventing Graft-versus-Host Disease in Adults Undergoing HLA-Matched Sibling Stem Cell Transplantation

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Greece
  • Study on the Safety and Effectiveness of SMART101 for Patients Undergoing Stem Cell Transplantation for Blood Cancers

    Recruiting

    2 1 1
    Investigated diseases:
    France Italy
  • Study on HPV Vaccine Timing for Patients After Stem Cell Transplantation Using Gardasil 9

    Recruiting

    2 1 1 1
    Investigated diseases:
    Sweden
  • Study of Posaconazole for Preventing Fungal Infections in Patients Receiving Stem Cell Transplants for Blood Cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on Letermovir for Preventing Cytomegalovirus in Stem Cell Transplant Patients with CMV-Positive Donors

    Recruiting

    2 1 1 1
    Investigated drugs:
    Spain
  • Study on Fludarabine, Melphalan, and ATG for Patients with Blood Cancer Undergoing Reduced Intensity Stem Cell Transplantation

    Recruiting

    3 1 1 1
    Investigated diseases:
    Belgium

References

https://www.mayoclinic.org/tests-procedures/allogeneic-stem-cell-transplant/pyc-20384863

https://www.cancer.gov/publications/dictionaries/cancer-terms/def/allogeneic-stem-cell-transplant

https://my.clevelandclinic.org/health/treatments/22790-allogeneic-stem-cell-transplantation

https://www.mskcc.org/cancer-care/diagnosis-treatment/cancer-treatments/blood-bone-marrow-stem-cell-transplants/allogeneic

https://www.hematology.org/education/trainees/fellows/hematopoiesis/2021/the-basics-of-allogeneic-transplantation

https://www.mdanderson.org/cancerwise/understanding-allogeneic-stem-cell-transplants–what-you-need-to-know.h00-159703068.html

https://www.mayoclinic.org/tests-procedures/allogeneic-stem-cell-transplant/pyc-20384863

https://my.clevelandclinic.org/health/treatments/22790-allogeneic-stem-cell-transplantation

https://www.mdanderson.org/cancerwise/understanding-allogeneic-stem-cell-transplants–what-you-need-to-know.h00-159703068.html

https://pmc.ncbi.nlm.nih.gov/articles/PMC3573422/

https://cancer.uams.edu/stem-cell-transplant/allogeneic/

https://www.cancer.org/cancer/types/acute-myeloid-leukemia/treating/bone-marrow-stem-cell-transplant.html

https://healthy.kaiserpermanente.org/health-wellness/health-encyclopedia/he.allogeneic-stem-cell-transplant.tv7978

https://www.mskcc.org/cancer-care/patient-education/allogeneic-stem-cell-transplantation

https://www.mdanderson.org/cancerwise/need-a-stem-cell-transplant–4-tips-to-make-your-life-easier.h00-159702279.html

https://www.fredhutch.org/en/news/spotlight/2024/06/crd-split-transplantcelltherapy.html

https://www.anthonynolan.org/patients-and-families/recovering-a-stem-cell-transplant

https://www.cancerresearchuk.org/about-cancer/acute-lymphoblastic-leukaemia-all/living-with/life-after-transplant

https://sctpatiented.dana-farber.org/precautions-inside-your-home1.html

https://www.mskcc.org/cancer-care/patient-education/leaving-hospital-after-your-allogeneic-transplant

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

How long does the diagnostic process take before an allogeneic stem cell transplant?

The diagnostic workup typically takes several weeks to complete. Basic tests like blood work and heart function tests can be done quickly, but finding a suitable donor can take weeks or even months if you need to search through donor registries. Your transplant team will schedule tests efficiently to avoid unnecessary delays.

Are the pre-transplant diagnostic tests painful?

Most diagnostic tests are not painful. Blood tests involve a quick needle stick, and imaging tests like X-rays, CT scans, and echocardiograms are completely painless. The bone marrow biopsy can be uncomfortable, but your doctor will use local anesthesia to numb the area and may give you medication to help you relax during the procedure.

What happens if my diagnostic tests show I’m not healthy enough for transplant right now?

If your tests reveal issues that need to be addressed first, your transplant may be delayed while you receive treatment to improve your health. For example, if you have an active infection, it will need to be treated before proceeding. Your medical team will work with you to optimize your health and determine when it’s safe to move forward with transplant.

Will I need to repeat these tests after my transplant?

Yes, ongoing monitoring after transplant is essential. You’ll have regular blood tests to check how well your new cells are working and to watch for complications. Your transplant team will oversee your recovery and provide any necessary treatments. The frequency of testing decreases over time as you recover, but some monitoring continues for months or years after transplant.

Can my siblings be tested as potential donors even if they live far away?

Yes, siblings can be tested for HLA compatibility regardless of where they live. The initial tissue typing test requires only a blood sample, which can be drawn at a local laboratory and sent to the transplant center for analysis. If a sibling is identified as a good match and agrees to donate, arrangements will be made for the donation process, which can often be coordinated at a collection center closer to where they live.

🎯 Key takeaways

  • Comprehensive diagnostic testing before allogeneic stem cell transplantation ensures you’re healthy enough for this intensive procedure and helps identify the best donor match.
  • Finding the right stem cell donor depends on HLA tissue typing—siblings have the best chance of matching, but unrelated donors can be found through national registries.
  • Pre-transplant tests include blood counts, heart function assessments, liver and kidney tests, and often a bone marrow biopsy to evaluate your disease status.
  • The diagnostic process can take several weeks to months, especially if searching for an unrelated donor is necessary.
  • Clinical trials have additional specific testing requirements and eligibility criteria designed to ensure patient safety and study reliability.
  • Most diagnostic tests are painless or cause only minor discomfort, with doctors using anesthesia and relaxation medications for more invasive procedures like bone marrow biopsies.
  • Ongoing diagnostic monitoring continues after transplant to track recovery, detect complications early, and assess how well your body is accepting the donated cells.
  • About 40% of people needing stem cell transplants receive donated cells, with the procedure typically recommended when initial treatments fail or conditions return.